Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Cosmos Pharmaceutical Corp?

Accepted Answer

Según el último estado financiero (Form-10K), Cosmos Pharmaceutical Corp tiene un total de activos de $524,755, una ganancia neta profit de $30,978

Question 2

¿Cuáles son los ratios financieros clave para CSMYF?

Accepted Answer

El ratio corriente de Cosmos Pharmaceutical Corp es 1.96, el margen neto es 3.06, las ventas por acción son $12,760.82.

Question 3

¿Cómo se desglosan los ingresos de Cosmos Pharmaceutical Corp por segmento o geografía?

Accepted Answer

Cosmos Pharmaceutical Corp largest revenue segment is General Food, at a revenue of 582,766,000,000 in the most earnings release.For geography, Japan is the primary market for Cosmos Pharmaceutical Corp, at a revenue of 964,989,000,000.

Question 4

¿Es rentable Cosmos Pharmaceutical Corp?

Accepted Answer

yes, según los últimos estados financieros, Cosmos Pharmaceutical Corp tiene una ganancia neta profit de $30,978

Question 5

¿Tiene Cosmos Pharmaceutical Corp alguna deuda?

Accepted Answer

yes, Cosmos Pharmaceutical Corp tiene una deuda de 267,292

Question 6

¿Cuántas acciones en circulación tiene Cosmos Pharmaceutical Corp?

Accepted Answer

Cosmos Pharmaceutical Corp tiene un total de acciones en circulación de 79.25

Breakdown	TTM	05/31/2025	05/31/2024	05/31/2023	05/31/2022	05/31/2021
Revenue	1,021,943	1,011,390	964,989	827,697	755,414	726,424
Revenue Growth (YoY)	4%	5%	17%	10%	4%	6%
Cost of Revenue	806,050	798,109	776,683	658,979	603,966	581,313
Gross Profit	215,893	213,281	188,306	168,718	151,448	145,111
Selling, General & Admin	175,424	152,430	138,536	122,807	107,756	99,163
Research & Development	--	--	--	--	--	--
Operating Expenses	175,424	172,877	156,805	138,590	121,652	111,964
Other Non Operating Income (Expenses)	2,837	2,962	2,853	2,962	3,065	2,691
Pretax Income	42,394	42,372	33,719	32,773	33,048	38,596
Income Tax Expense	11,387	11,393	9,265	8,975	9,892	11,439
Net Income	31,006	30,978	24,454	23,797	23,155	27,156
Net Income Growth	19%	27%	3%	3%	-15%	27%
Shares Outstanding (Diluted)	79.25	79.25	79.23	79.19	79.19	39.59
Shares Change (YoY)	0%	0%	0%	0%	100%	0%
EPS (Diluted)	391.2	390.85	308.6	300.47	292.36	685.77
EPS Growth	19%	27%	3%	3%	-56.99%	27%
Free Cash Flow	--	-859	-635	7,798	-11,303	1,809
Free Cash Flow Per Share	--	-10.83	-8.01	98.46	-142.71	45.68
Gross Margin	21.12%	21.08%	19.51%	20.38%	20.04%	19.97%
Operating Margin	3.96%	3.99%	3.26%	3.63%	3.94%	4.56%
Profit Margin	3.03%	3.06%	2.53%	2.87%	3.06%	3.73%
Free Cash Flow Margin	--	-0.08%	-0.06%	0.94%	-1.49%	0.24%
EBITDA	--	62,633	51,425	47,496	44,906	46,932
EBITDA Margin	--	6.19%	5.32%	5.73%	5.94%	6.46%
D&A For EBITDA	--	22,229	19,924	17,368	15,110	13,785
EBIT	40,469	40,404	31,501	30,128	29,796	33,147
EBIT Margin	3.96%	3.99%	3.26%	3.63%	3.94%	4.56%
Effective Tax Rate	26.85%	26.88%	27.47%	27.38%	29.93%	29.63%

Cosmos Pharmaceutical Corp (CSMYF) Price

CSMYF Stock Price Chart

CSMYF Income

Follow-Up Questions